{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:31:16Z","timestamp":1768714276916,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,20]],"date-time":"2010-03-20T00:00:00Z","timestamp":1269043200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s11255-010-9725-8","type":"journal-article","created":{"date-parts":[[2010,3,19]],"date-time":"2010-03-19T02:29:04Z","timestamp":1268965744000},"page":"175-184","source":"Crossref","is-referenced-by-count":45,"title":["Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"43","author":[{"given":"Mirela","family":"Dobre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevag","family":"Demirjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwini R.","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sankar D.","family":"Navaneethan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,20]]},"reference":[{"key":"9725_CR1","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM196906192802501","volume":"280","author":"MH Koppel","year":"1969","unstructured":"Koppel MH, Coburn JW, Mims MM et al (1969) Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease. N Engl J Med 280:1367\u20131371","journal-title":"N Engl J Med"},{"key":"9725_CR2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9343(70)80073-0","volume":"49","author":"M Epstein","year":"1970","unstructured":"Epstein M, Berk DP, Hollenberg NK et al (1970) Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 49:175\u2013185","journal-title":"Am J Med"},{"key":"9725_CR3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0749-0704(02)00051-9","volume":"19","author":"A Krasko","year":"2003","unstructured":"Krasko A, Deshpande K, Bonvino S (2003) Liver failure, transplantation, and critical care. Crit Care Clin 19:155\u2013183","journal-title":"Crit Care Clin"},{"key":"9725_CR4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","volume":"105","author":"A Gin\u00e8s","year":"1993","unstructured":"Gin\u00e8s A, Escorsell A, Gin\u00e8s P et al (1993) Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105:229\u2013236","journal-title":"Gastroenterology"},{"key":"9725_CR5","unstructured":"http:\/\/www.icascites.org\/guidelines.htm . Last accessed February 12, 2010"},{"key":"9725_CR6","first-page":"159","volume":"48","author":"RA Lafayette","year":"1997","unstructured":"Lafayette RA, Par\u00e9 G, Schmid CH et al (1997) Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol 48:159\u2013164","journal-title":"Clin Nephrol"},{"key":"9725_CR7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","volume":"40","author":"T Restuccia","year":"2004","unstructured":"Restuccia T, Ortega R, Guevara M et al (2004) Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol 40:140\u2013146","journal-title":"J Hepatol"},{"key":"9725_CR8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","volume":"41","author":"C Alessandria","year":"2005","unstructured":"Alessandria C, Ozdogan O, Guevara M et al (2005) MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 41:1282\u20131289","journal-title":"Hepatology"},{"key":"9725_CR9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfi212","volume":"21","author":"PE Marik","year":"2006","unstructured":"Marik PE, Wood K, Starzl TE (2006) The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant 21:478\u2013482","journal-title":"Nephrol Dial Transplant"},{"key":"9725_CR10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"RW Schrier","year":"1988","unstructured":"Schrier RW, Arroyo V, Bernardi M et al (1988) Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151\u20131157","journal-title":"Hepatology"},{"key":"9725_CR11","doi-asserted-by":"crossref","unstructured":"Moreau R, Lebrec D (2008) Acute kidney injury: new concepts. Hepatorenal syndrome: the role of vasopressors. Nephron Physiol 109(4):73\u201379","DOI":"10.1159\/000142939"},{"key":"9725_CR12","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","volume":"48","author":"G Garcia-Tsao","year":"2008","unstructured":"Garcia-Tsao G, Parikh CR, Viola A (2008) Acute kidney injury in cirrhosis. Hepatology 48:2064\u20132077","journal-title":"Hepatology"},{"key":"9725_CR13","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","volume":"52","author":"E Esrailian","year":"2007","unstructured":"Esrailian E, Pantangco ER, Kyulo NL, Hu KQ, Runyon BA (2007) Octreotide\/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig Dis Sci 52:742\u2013748","journal-title":"Dig Dis Sci"},{"key":"9725_CR14","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1572-0241.2005.40899.x","volume":"100","author":"G Kalambokis","year":"2005","unstructured":"Kalambokis G, Economou M, Fotopoulos A et al (2005) The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites. Am J Gastroenterol 100:879\u2013885","journal-title":"Am J Gastroenterol"},{"key":"9725_CR15","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","volume":"103","author":"P Sharma","year":"2008","unstructured":"Sharma P, Kumar A, Shrama BC, Sarin SK (2008) An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Am J Gastroenterol 103:1689\u20131697","journal-title":"Am J Gastroenterol"},{"key":"9725_CR16","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","volume":"134","author":"AJ Sanyal","year":"2008","unstructured":"Sanyal AJ, Boyer T, Garcia-Tsao G et al (2008) A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134:1360\u20131368","journal-title":"Gastroenterology"},{"key":"9725_CR17","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","volume":"134","author":"M Mart\u00edn-Llah\u00ed","year":"2008","unstructured":"Mart\u00edn-Llah\u00ed M, P\u00e9pin MN, Guevara M et al (2008) Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 134:1352\u20131359","journal-title":"Gastroenterology"},{"key":"9725_CR18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","volume":"47","author":"C Alessandria","year":"2007","unstructured":"Alessandria C, Ottobrelli A, Debernardi-Venon W et al (2007) Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. J Hepatol 47:499\u2013505","journal-title":"J Hepatol"},{"key":"9725_CR19","doi-asserted-by":"crossref","unstructured":"Testro AG, Wongseelashote S, Angus PW, Gow PJ (2008) Long-term outcome of patients treated with terlipressin for types 1 and 2 hepatorenal syndrome. J Gastroenterol Hepatol 23(10):153\u2013158","DOI":"10.1111\/j.1440-1746.2007.05176.x"},{"key":"9725_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1\u201312","journal-title":"Control Clin Trials"},{"key":"9725_CR21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"9725_CR22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"9725_CR23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","volume":"18","author":"P Solanki","year":"2003","unstructured":"Solanki P, Chawla A, Garg R, Gupta R, Jain M, Sarin SK (2003) Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol 18:152\u2013156","journal-title":"J Gastroenterol Hepatol"},{"key":"9725_CR24","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","volume":"53","author":"S Neri","year":"2008","unstructured":"Neri S, Pulvirenti D, Malaguarnera M et al (2008) Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome. Dig Dis Sci 53:830\u2013835","journal-title":"Dig Dis Sci"},{"key":"9725_CR25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0168-8278(98)80151-7","volume":"29","author":"A Hadengue","year":"1998","unstructured":"Hadengue A, Gadano A, Moreau R et al (1998) Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol 29:565\u2013570","journal-title":"J Hepatol"},{"key":"9725_CR26","first-page":"123","volume":"7","author":"YZ Yang","year":"2001","unstructured":"Yang YZ, Dan ZL, Liu NZ, Liu M et al (2001) Efficacy of terlipressin in treatment of liver cirrhosis with hepatorenal syndrome. J Inter Intensive Med 7:123\u2013125","journal-title":"J Inter Intensive Med"},{"key":"9725_CR27","doi-asserted-by":"crossref","unstructured":"Gluud LL, Kjaer MS, Christensen E (2006) Terlipressin for hepatorenal syndrome. Cochrane Database Syst Rev 4:CD005162","DOI":"10.1002\/14651858.CD005162.pub2"},{"key":"9725_CR28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1365-2036.2006.03086.x","volume":"24","author":"F Fabrizi","year":"2006","unstructured":"Fabrizi F, Dixit V, Martin P (2006) Meta-analysis: terlipressin therapy for the hepatorenal syndrome. Aliment Pharmacol Ther 24:935\u2013944","journal-title":"Aliment Pharmacol Ther"},{"key":"9725_CR29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/039139880903200303","volume":"32","author":"F Fabrizi","year":"2009","unstructured":"Fabrizi F, Dixit V, Messa P, Martin P (2009) Terlipressin for hepatorenal syndrome: a meta-analysis of randomized trials. Int J Artif Organs 32:133\u2013140","journal-title":"Int J Artif Organs"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-010-9725-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-010-9725-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-010-9725-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:55:33Z","timestamp":1559375733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-010-9725-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,20]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9725"],"URL":"https:\/\/doi.org\/10.1007\/s11255-010-9725-8","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,20]]}}}